Leerink partners set a $152.00 target price on Encompass Health shares.
1 report, 1 independent
Updated Jul 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Leerink partners set a $152.00 target price on Encompass Health shares.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Leerink partners
U.S. investment bank
-
Encompass Health
American health care company
Nothing else this week.
Related events
- Leerink Partners, Truist Financial, HSBC, and Cantor Fitzgerald raised target prices on various stocks on October 9, 2026.
- Leerink Partners increased its price target and Morgan Stanley reiterated an overweight rating for REGENXBIO Inc.
- Leerink Partners and Barclays raised price targets on Elevance Health, while MarketBeat reported consensus ratings.
- Leerink Partners started coverage on Nautilus Biotechnology on October 6, 2026.
- Citigroup reissued a market outperform rating and Leerink Partners began coverage on Rapport Therapeutics.